InvestorsHub Logo
Followers 75
Posts 4838
Boards Moderated 2
Alias Born 08/21/2015

Re: None

Thursday, 09/24/2020 1:38:51 PM

Thursday, September 24, 2020 1:38:51 PM

Post# of 9965
Therapeutic Window of Use: The Chemistry of Success

This is my own editorial post on why this company will be one of the biggest players in this space. I was taught at a young age by a chemist that all substances on this planet have what is known as a "Therapeutic Window of Use" - meaning simply that anything dialed in correctly will show signs of positive use.

Sodium Chloride. Regular table salt can kill you easily. But a minute amount makes food taste good and is good for water retention. Hence why sports drinks contain a small amount.

Getting into more complex spaces like ADHD and other ailments like narcolepsy (which is the complete opposite of ADHD) you start to look at how some chemicals are abused to get high. For example... look at Adderall and Ritalin. Both of these drugs can speed up or slow down a person and change the chemistry in the brain. Usually having the opposite effect of what is intended if not prescribed or used correctly or as intended. This is an extremely basic case for those examples and I am not a chemist nor is this post supposed to be one.

However, when you look at the science behind LSD it becomes extremely similar in case... too much... you see things that are not there... just enough and you see things a little differently. It is tight tolerances and tweaking at it finest.

Then look at the laws and politics behind drugs... Take Ritalin for example - Ritalin (Methylphenidate) was first made in 1944 and was approved for medical use in the United States in 1955. It was originally sold by Swiss company CIBA, now Novartis Corporation. It is estimated that in 2013, 2.4 billion doses of methylphenidate were taken worldwide. In 2017, it was the 47th-most commonly prescribed medication in the United States, with more than 16 million prescriptions. It is available as a generic medication.

What becomes interesting is the time lines... prior to Ritalin... LSD was studied, synthesized, but then outlawed. Ritalin is now a generic (aka. the patent expired)

Now, even more intriguing to me is that the man behind LSD, Albert Hoffman, whom became an employee of the pharmaceutical/chemical department of Sandoz Laboratories (now a subsidiary of Novartis), located in Basel. Novartis was the company (then CIBA) who actually developed the drug... Now that psychedelics are becoming mainstream... there is a lot of IP starting to surround this. One day soon... MindMed will be the company behind a safer and more rational class of drugs to treat the illnesses which we were poisoning people at one time and still are.

Things are going to get really interesting here folks... strap in. This is not your typical OTC company at all. Something big is at play here... You thought the Cannabis Boom was big. You haven't seen anything yet. And screw the "Mush Rush"... this is even bigger than the idea of that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News